RHOADS ANN D 4

What Happened
Ann D. Rhoads, a director of Globus Medical, reported exercising stock options (transaction code M) to acquire 25,000 shares at an exercise price of $26.27 per share, for a total cash outlay of $656,750. The Form 4 also shows a separate derivative disposition for 25,000 shares at $0.00 on the same date.

Key Details

• Transaction date: 2026-06-04; Form 4 filed 2026-06-08 (filing appears timely under the 2-business-day rule).
• Exercise: 25,000 shares acquired at $26.27 each; aggregate $656,750. (Code M = option exercise/conversion.)
• Derivative disposition: 25,000 shares at $0.00 reported the same date (filing does not specify the reason for this disposition).
• Footnote: These options were granted January 30, 2017 and are fully vested.
• Shares owned after the transaction: Not specified in the provided filing details.

Context

• Code M entries indicate an exercise or conversion of a derivative (options). The separate $0.00 disposition on the same number of shares may reflect internal settlement mechanics (e.g., share withholding or surrender), but the Form 4 does not state the reason.
• For retail investors: exercises (even without open-market sales) show insiders converting vested options into shares; purchases can be interpreted as a personal investment, while exercises alone may simply reflect option vesting and standard insider activity. This report is informational and does not explain the insider’s motive.